Case report: sudden death following the administration of CAR-NK cells for lung cancer immunotherapy

Forensic Sci Med Pathol. 2024 Jun;20(2):690-695. doi: 10.1007/s12024-023-00693-4. Epub 2023 Aug 5.

Abstract

Lung cancer is a high degree of malignancy. Although surgery, radiotherapy, and chemotherapy have made significant progress and become general methods of clinical treatment, the overall survival rate is still low. In recent years, targeted therapy and immunotherapy have a rapid development in the clinical treatment of tumors. Among them, natural killer (NK) cells have the advantages of rapid killing of diseased cells and low risk of graft-versus-host reaction. It is considered a great vector for chimeric antigen receptors (CARs), making them have good application prospects in tumor immunotherapy. However, its clinical application in lung cancer needs further research. Herein, we reported a case of a lung cancer patient undergoing CAR-NK cell immunotherapy after resection, which caused a cytokine storm and sudden death after the fourth treatment. This case report provides a reference for the forensic examination of cadavers that died after immunotherapy and challenges the clinical application of cell immunotherapy.

Keywords: CAR-NK cells; Cytokine storm; Immunotherapy; Inflammatory factors; Lung cancer.

Publication types

  • Case Reports

MeSH terms

  • Cytokine Release Syndrome / etiology
  • Cytokine Release Syndrome / therapy
  • Death, Sudden* / etiology
  • Humans
  • Immunotherapy
  • Immunotherapy, Adoptive*
  • Killer Cells, Natural*
  • Lung Neoplasms* / pathology
  • Lung Neoplasms* / therapy
  • Male
  • Middle Aged
  • Receptors, Chimeric Antigen* / therapeutic use

Substances

  • Receptors, Chimeric Antigen